Youqian Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Youqian Zhang has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Yao Ni
Department of Dermatovenereology Chengdu Second People's Hospital Chengdu Sichuan China
4 shared publications- Mingwei Chen
Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China
2 shared publications - Yanyan Feng
West China School of Medicine, Sichuan University, Sichuan University Affiliated Chengdu Second People’s Hospital, Chengdu Second People’s Hospital
2 shared publications - Yao Ni
Department of Dermatovenereology, Chengdu Second People’s Hospital, Chengdu, Sichuan Province, People’s Republic of China
2 shared publications Chang Liu
Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi’an Jiaotong University
1 shared publicationDaWei Zhang
Department of Clinical Laboratory, Chengdu Second People’s Hospital, Chengdu, Sichuan, China
1 shared publication
Latest Publications
- 20 August 2026
- Published by American Diabetes Association in Diabetes Care
- Vol. 49 (9) , e156-e157
Comment on Di Marco et al. Metabolic Factors Modulating the Connection Between Diabetes and Pulmonary Alterations
- 20 August 2026
- Published by American Diabetes Association in Diabetes Care
- Vol. 49 (9) , e156-e157
Comment on Di Marco et al. Metabolic Factors Modulating the Connection Between Diabetes and Pulmonary Alterations
- Open Access
- 7 December 2025
- Published by Taylor & Francis in Clinical and Experimental Hypertension
- Vol. 47 (1) , 2595152
Iron status mediates the causal effects of high-altitude adaptation signals in the HIF–PHD axis on pulmonary vascular and right-heart outcomes
The high-altitude adaptation genes EPAS1 (HIF-2α) and EGLN1 (PHD2) in the HIF-PHD oxygen-sensing pathway regulate erythropoiesis and iron homeostasis and are implicated in hypoxia-related pulmonary vascular disease, yet causal roles are unclear. This study applied a drug-target Mendelian randomization (DTMR) framework. Cis-eQTLs were used to instrument EPAS1/EGLN1 expression; gene-restricted erythroid instruments were built from genome-wide significant variants within ± 100 kb for hemoglobin (HGB), hematocrit (HCT), and red blood cell count (RBC). Primary analyses used inverse-variance weighted (IVW) and summary-data-based Mendelian randomization (SMR) with eight sensitivity approaches. Outcomes included pulmonary embolism (PE), pulmonary arterial hypertension (PAH), pulmonary-artery structural indices, and right-heart MRI traits. Two-step mediation MR evaluated iron-status traits. In SMR-DTMR, higher EPAS1 expression associated with lower PE risk (OR = 0.861; 95% CI, 0.758-0.979). In IVW-DTMR, EGLN1-mediated increases in HGB/HCT/RBC raised PE risk (HGB: OR 2.55; HCT: OR 2.45; RBC: OR 1.91) and were associated with lower systolic pulmonary artery-to-aorta ratio (PA/Ao) (HGB β-0.322; HCT β-0.282; RBC β-0.425). EPAS1-mediated HGB/HCT/RBC were associated with reduced right ventricular peak filling rate (RVP-FR; β-33.8 to -28.1). Mediation indicated serum iron partially mediated the EGLN1→(HGB/HCT)→PE pathway (3.6-3.8%), with a potential effect for RBC; ferritin potentially mediated the EPAS1→RBC→PA/Ao pathway. Multiple sensitivity analyses supported robustness. EGLN1-driven erythropoietic upregulation increases PE risk and adversely affects pulmonary artery structure, whereas higher EPAS1 expression reduces PE risk. These genetic findings support targeted modulation of HIF-2α and iron metabolism.
- 7 December 2025
- Published by Taylor & Francis in Clinical and Experimental Hypertension
- Vol. 47 (1) , 2595152
Open AccessIron status mediates the causal effects of high-altitude adaptation signals in the HIF–PHD axis on pulmonary vascular and right-heart outcomes
The high-altitude adaptation genes EPAS1 (HIF-2α) and EGLN1 (PHD2) in the HIF-PHD oxygen-sensing pathway regulate erythropoiesis and iron homeostasis and are implicated in hypoxia-related pulmonary vascular disease, yet causal roles are unclear. This study applied a drug-target Mendelian randomization (DTMR) framework. Cis-eQTLs were used to instrument EPAS1/EGLN1 expression; gene-restricted erythroid instruments were built from genome-wide significant variants within ± 100 kb for hemoglobin (HGB), hematocrit (HCT), and red blood cell count (RBC). Primary analyses used inverse-variance weighted (IVW) and summary-data-based Mendelian randomization (SMR) with eight sensitivity approaches. Outcomes included pulmonary embolism (PE), pulmonary arterial hypertension (PAH), pulmonary-artery structural indices, and right-heart MRI traits. Two-step mediation MR evaluated iron-status traits. In SMR-DTMR, higher EPAS1 expression associated with lower PE risk (OR = 0.861; 95% CI, 0.758-0.979). In IVW-DTMR, EGLN1-mediated increases in HGB/HCT/RBC raised PE risk (HGB: OR 2.55; HCT: OR 2.45; RBC: OR 1.91) and were associated with lower systolic pulmonary artery-to-aorta ratio (PA/Ao) (HGB β-0.322; HCT β-0.282; RBC β-0.425). EPAS1-mediated HGB/HCT/RBC were associated with reduced right ventricular peak filling rate (RVP-FR; β-33.8 to -28.1). Mediation indicated serum iron partially mediated the EGLN1→(HGB/HCT)→PE pathway (3.6-3.8%), with a potential effect for RBC; ferritin potentially mediated the EPAS1→RBC→PA/Ao pathway. Multiple sensitivity analyses supported robustness. EGLN1-driven erythropoietic upregulation increases PE risk and adversely affects pulmonary artery structure, whereas higher EPAS1 expression reduces PE risk. These genetic findings support targeted modulation of HIF-2α and iron metabolism.
- Open Access
- 15 May 2025
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 16, 1411587
Psychological, social factors, and smoking behavior mediated the effects of cannabis use on personality disorders: A Mendelian randomization study
Background: Rapid changes in attitudes, legality, and patterns of cannabis use (CU) underscore the importance of understanding its impact on mental health. Although links between CU and personality disorders (PDs) are documented, their causality remains uncertain.Methods: Employing Genome-Wide Association Studies (GWAS) data, this study investigated the causal relationship between cannabis use disorder (CUD) and lifetime cannabis use (LCU) with 9 types of PD risk through Mendelian randomization (MR) analysis. The primary method was the inverse variance weighted (IVW) method, supplemented by multivariable MR to assess direct effects independent of mental, social, and substance use factors, and mediation MR to explore mediating factors.Results: Corrections for the false discovery rate revealed significant causal associations between CUD and an increased risk of emotionally unstable PD (EUPD; ORIVW = 1.228, 95% CI 1.069–1.411), overall PD (ORIVW = 1.186, 95% CI 1.065–1.321), and schizoid PD (SPD; ORIVW = 1.644, 95% CI 1.131–2.390). Mediation analysis identified schizophrenia (SCZ), major depressive disorder (MDD), neuroticism, and smoking initiation (SmkInit) as shared mediating factors between CUD and both EUPD and overall PD, with an additional mediating factor, household income (HI), specific to the CUD-to-overall PD pathway. In contrast, no mediating factors were found between CUD and SPD. Notably, a bidirectional causal relationship was observed between overall PD and CUD (ORIVW = 1.399, 95% CI 1.033–1.895). Suggestive evidence indicated a causal link between lifetime cannabis use (LCU) and overall PD risk (ORIVW = 1.074, 95% CI 1.008–1.146).Conclusion: This study offers new insights into the potential impact of CU on the development and progression of various PDs, laying the groundwork for targeted interventions to mitigate its effects on mental health.
- 15 May 2025
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 16, 1411587
Open AccessPsychological, social factors, and smoking behavior mediated the effects of cannabis use on personality disorders: A Mendelian randomization study
Background: Rapid changes in attitudes, legality, and patterns of cannabis use (CU) underscore the importance of understanding its impact on mental health. Although links between CU and personality disorders (PDs) are documented, their causality remains uncertain.Methods: Employing Genome-Wide Association Studies (GWAS) data, this study investigated the causal relationship between cannabis use disorder (CUD) and lifetime cannabis use (LCU) with 9 types of PD risk through Mendelian randomization (MR) analysis. The primary method was the inverse variance weighted (IVW) method, supplemented by multivariable MR to assess direct effects independent of mental, social, and substance use factors, and mediation MR to explore mediating factors.Results: Corrections for the false discovery rate revealed significant causal associations between CUD and an increased risk of emotionally unstable PD (EUPD; ORIVW = 1.228, 95% CI 1.069–1.411), overall PD (ORIVW = 1.186, 95% CI 1.065–1.321), and schizoid PD (SPD; ORIVW = 1.644, 95% CI 1.131–2.390). Mediation analysis identified schizophrenia (SCZ), major depressive disorder (MDD), neuroticism, and smoking initiation (SmkInit) as shared mediating factors between CUD and both EUPD and overall PD, with an additional mediating factor, household income (HI), specific to the CUD-to-overall PD pathway. In contrast, no mediating factors were found between CUD and SPD. Notably, a bidirectional causal relationship was observed between overall PD and CUD (ORIVW = 1.399, 95% CI 1.033–1.895). Suggestive evidence indicated a causal link between lifetime cannabis use (LCU) and overall PD risk (ORIVW = 1.074, 95% CI 1.008–1.146).Conclusion: This study offers new insights into the potential impact of CU on the development and progression of various PDs, laying the groundwork for targeted interventions to mitigate its effects on mental health.
- Open Access
- 4 April 2025
- Published by Wiley in Journal of Diabetes Investigation
- Vol. 16 (6) , 1138-1140
The causal relationship between gestational diabetes mellitus and postpartum depression: A Mendelian randomization study
There is no evidence of a causal relationship between GDM and PPD in European populations. Future research should explore this association in diverse ancestries and investigate the link between GDM and antenatal depression.
- 4 April 2025
- Published by Wiley in Journal of Diabetes Investigation
- Vol. 16 (6) , 1138-1140
Open AccessThe causal relationship between gestational diabetes mellitus and postpartum depression: A Mendelian randomization study
There is no evidence of a causal relationship between GDM and PPD in European populations. Future research should explore this association in diverse ancestries and investigate the link between GDM and antenatal depression.
- Open Access
- 12 October 2024
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 36 (1) , 1-12
Exploring the relationship between sarcopenia and 11 respiratory diseases: a comprehensive mendelian randomization analysis
Background: Sarcopenia (SP) is an aging-related loss of muscle mass and function, affecting the respiratory system. However, the causality of the association between sarcopenia on lung diseases remains elusive. Methods: The bidirectional univariate Mendelian randomization (UVMR), multivariate MR (MVMR) analysis, and mediation MR were utilized to systematically investigate the genetic causal relationship of SP and 11 respiratory diseases. Independent genomic variants related to sarcopenia or respiratory diseases were identified as instrumental variables (IVs), and the summary level data of genome-wide associated studies (GWAS) were obtained from the UK biobank and FinnGen. MVMR analysis was conducted to explore the mediation effects of body mass index (BMI), Alcohol Use Disorders Identification Test (AUDIT), smoking, education attainment (EA), physical activity, and Type 2 Diabetes Mellitus (T2DM). Results: Forward UVMR analysis based on the primary method revealed that pneumoconiosis was associated with a higher risk of appendicular lean mass (ALM) (OR = 1.01, p = 0.03), and BMI (10.65%), smoking (10.65%), and physical activity (17.70%) had a mediating role in the effect of pneumoconiosis on ALM. In reverse MR analysis, we found that genetically predicted ALM was significantly associated with an increased risk of pulmonary embolism (PE) (OR = 1.24, p = 7.21E-05). Chronic obstructive pulmonary disease (COPD) (OR = 0.98, p = 0.002) and sarcoidosis (OR = 1.01, p = 0.004) were identified to increase the loss of left-hand grip strength (HGS). Conversely, the increase in left- HGS presented a protective effect on chronic bronchitis (CB) (OR = 0.35, p = 0.03), (OR = 0.80, p = 0.02), and asthma (OR = 0.78, p = 0.04). Similarly, the loss of the right-HGS elevated the risk of low respiratory tract infection (LRTI) (OR = 0.97, p = 0.02) and bronchiectasis (OR = 1.01, p = 0.03), which is also an independent protective factor for LRTI and asthma. In the aspects of low HGS, the risk of LRTI was increased after MVMR analysis, and the risk of sarcoidosis and pneumoconiosis was elevated in the reverse analysis. Lastly, asthma was found to be related to the loss of the usual walking pace, and the reverse MR analysis suggested a causal relationship between the usual walking pace and LRTI (OR = 0.32, p = 2.79 × 10−5), asthma (OR = 0.24, p = 2.09 × 10−6), COPD (OR = 0.22, p = 6.64 × 10−4), and PE(OR = 0.35, p = 0.03). Conclusions: This data-driven MR analysis revealed SP was bidirectional causally associated with lung diseases, providing genetic evidence for further mechanistic and clinical studies to understand the crosstalk between SP and lung diseases.
- 12 October 2024
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 36 (1) , 1-12
Open AccessExploring the relationship between sarcopenia and 11 respiratory diseases: a comprehensive mendelian randomization analysis
Background: Sarcopenia (SP) is an aging-related loss of muscle mass and function, affecting the respiratory system. However, the causality of the association between sarcopenia on lung diseases remains elusive. Methods: The bidirectional univariate Mendelian randomization (UVMR), multivariate MR (MVMR) analysis, and mediation MR were utilized to systematically investigate the genetic causal relationship of SP and 11 respiratory diseases. Independent genomic variants related to sarcopenia or respiratory diseases were identified as instrumental variables (IVs), and the summary level data of genome-wide associated studies (GWAS) were obtained from the UK biobank and FinnGen. MVMR analysis was conducted to explore the mediation effects of body mass index (BMI), Alcohol Use Disorders Identification Test (AUDIT), smoking, education attainment (EA), physical activity, and Type 2 Diabetes Mellitus (T2DM). Results: Forward UVMR analysis based on the primary method revealed that pneumoconiosis was associated with a higher risk of appendicular lean mass (ALM) (OR = 1.01, p = 0.03), and BMI (10.65%), smoking (10.65%), and physical activity (17.70%) had a mediating role in the effect of pneumoconiosis on ALM. In reverse MR analysis, we found that genetically predicted ALM was significantly associated with an increased risk of pulmonary embolism (PE) (OR = 1.24, p = 7.21E-05). Chronic obstructive pulmonary disease (COPD) (OR = 0.98, p = 0.002) and sarcoidosis (OR = 1.01, p = 0.004) were identified to increase the loss of left-hand grip strength (HGS). Conversely, the increase in left- HGS presented a protective effect on chronic bronchitis (CB) (OR = 0.35, p = 0.03), (OR = 0.80, p = 0.02), and asthma (OR = 0.78, p = 0.04). Similarly, the loss of the right-HGS elevated the risk of low respiratory tract infection (LRTI) (OR = 0.97, p = 0.02) and bronchiectasis (OR = 1.01, p = 0.03), which is also an independent protective factor for LRTI and asthma. In the aspects of low HGS, the risk of LRTI was increased after MVMR analysis, and the risk of sarcoidosis and pneumoconiosis was elevated in the reverse analysis. Lastly, asthma was found to be related to the loss of the usual walking pace, and the reverse MR analysis suggested a causal relationship between the usual walking pace and LRTI (OR = 0.32, p = 2.79 × 10−5), asthma (OR = 0.24, p = 2.09 × 10−6), COPD (OR = 0.22, p = 6.64 × 10−4), and PE(OR = 0.35, p = 0.03). Conclusions: This data-driven MR analysis revealed SP was bidirectional causally associated with lung diseases, providing genetic evidence for further mechanistic and clinical studies to understand the crosstalk between SP and lung diseases.
- Open Access
- 13 August 2024
- Published by Oxford University Press (OUP) in Sexual Medicine
- Vol. 12 (4) , qfae058
Letter to the Editor on “Causal associations between prostate diseases, renal diseases, renal function, and erectile dysfunction risk: a 2-sample Mendelian randomization study”
- 13 August 2024
- Published by Oxford University Press (OUP) in Sexual Medicine
- Vol. 12 (4) , qfae058
Open AccessLetter to the Editor on “Causal associations between prostate diseases, renal diseases, renal function, and erectile dysfunction risk: a 2-sample Mendelian randomization study”
- Open Access
- 22 May 2024
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 15, 1405107
Body mass index, smoking behavior, and depression mediated the effects of schizophrenia on chronic obstructive pulmonary disease: trans-ethnic Mendelian-randomization analysis
Background: Previous studies have highlighted the association between schizophrenia (SCZ) and chronic obstructive pulmonary disease (COPD), yet the causal relationship remains unestablished.Methods: Under the genome-wide significance threshold (P8), data from individuals of European (EUR) and East Asian (EAS) ancestries with SCZ were selected for analysis. Univariable Mendelian randomization (MR) explored the causal relationship between SCZ and COPD. Linkage disequilibrium score (LDSC) regression was used to calculate genetic correlation, while multivariable and mediation MR further investigated the roles of six confounding factors and their mediating effects. The primary method utilized was inverse-variance weighted (IVW), complemented by a series of sensitivity analyses and false discovery rate (FDR) correction.Results: LDSC analysis revealed a significant genetic correlation between SCZ and COPD within EUR ancestry (rg = 0.141, P = 6.16×10–7), with no such correlation found in EAS ancestry. IVW indicated a significant causal relationship between SCZ and COPD in EUR ancestry (OR = 1.042, 95% CI 1.013–1.071, P = 0.003, PFDR= 0.015). Additionally, replication datasets provide evidence of consistent causal associations(P < 0.05 & PFDR < 0.05). Multivariable and mediation MR analyses identified body mass index (BMI)(Mediation effect: 50.57%, P = 0.02), age of smoking initiation (Mediation effect: 27.42%, P = 0.02), and major depressive disorder (MDD) (Mediation effect: 60.45%, P = 6.98×10–5) as partial mediators of this causal relationship. No causal associations were observed in EAS (OR = 0.971, 95% CI 0.875–1.073, P = 0.571, PFDR= 0.761) ancestry. No causal associations were found in the reverse analysis across the four ancestries (P > 0.05 & PFDR > 0.05).Conclusions: This study confirmed a causal relationship between SCZ and the risk of COPD in EUR ancestry, with BMI, smoking, and MDD serving as key mediators. Future research on a larger scale is necessary to validate the generalizability of these findings across other ancestries.
- 22 May 2024
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 15, 1405107
Open AccessBody mass index, smoking behavior, and depression mediated the effects of schizophrenia on chronic obstructive pulmonary disease: trans-ethnic Mendelian-randomization analysis
Background: Previous studies have highlighted the association between schizophrenia (SCZ) and chronic obstructive pulmonary disease (COPD), yet the causal relationship remains unestablished.Methods: Under the genome-wide significance threshold (P8), data from individuals of European (EUR) and East Asian (EAS) ancestries with SCZ were selected for analysis. Univariable Mendelian randomization (MR) explored the causal relationship between SCZ and COPD. Linkage disequilibrium score (LDSC) regression was used to calculate genetic correlation, while multivariable and mediation MR further investigated the roles of six confounding factors and their mediating effects. The primary method utilized was inverse-variance weighted (IVW), complemented by a series of sensitivity analyses and false discovery rate (FDR) correction.Results: LDSC analysis revealed a significant genetic correlation between SCZ and COPD within EUR ancestry (rg = 0.141, P = 6.16×10–7), with no such correlation found in EAS ancestry. IVW indicated a significant causal relationship between SCZ and COPD in EUR ancestry (OR = 1.042, 95% CI 1.013–1.071, P = 0.003, PFDR= 0.015). Additionally, replication datasets provide evidence of consistent causal associations(P < 0.05 & PFDR < 0.05). Multivariable and mediation MR analyses identified body mass index (BMI)(Mediation effect: 50.57%, P = 0.02), age of smoking initiation (Mediation effect: 27.42%, P = 0.02), and major depressive disorder (MDD) (Mediation effect: 60.45%, P = 6.98×10–5) as partial mediators of this causal relationship. No causal associations were observed in EAS (OR = 0.971, 95% CI 0.875–1.073, P = 0.571, PFDR= 0.761) ancestry. No causal associations were found in the reverse analysis across the four ancestries (P > 0.05 & PFDR > 0.05).Conclusions: This study confirmed a causal relationship between SCZ and the risk of COPD in EUR ancestry, with BMI, smoking, and MDD serving as key mediators. Future research on a larger scale is necessary to validate the generalizability of these findings across other ancestries.
- 17 May 2024
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 34 (9) , 2075-2084
Multidimensional plasma lipid composition and its causal association with type 2 diabetes mellitus: A Mendelian randomization study
- 17 May 2024
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 34 (9) , 2075-2084
Multidimensional plasma lipid composition and its causal association with type 2 diabetes mellitus: A Mendelian randomization study